Does SelectHealth Cover Wegovy in 2026?

Does SelectHealth cover Wegovy? There is no one company-wide answer. Commercial coverage depends on your exact benefit and formulary: RxCore, RxSelect, or short-term RxBasic. Community Care excludes Wegovy for weight loss. The published FEHB formulary lists Zepbound, not Wegovy. Select Health Medicare removed Wegovy from its standard 2026 formulary, but diagnosis-specific review and the $50 federal Bridge may still apply.

Here's the part almost nobody tells you: the word "SelectHealth" on your card isn't enough to answer this question. Select Health has several coverage paths, and different rulebooks control them. Your commercial plan design controls one. Federal Part D rules control another. Utah Medicaid separates managed care from fee-for-service. OPM sets a federal floor for FEHB plans.

Get your plan type wrong and you can spend weeks filing paperwork that cannot solve the real problem.

So we went and opened the documents. All of them.

This page is for you if

• You have a Select Health card and a Wegovy prescription — or you're about to get one
• Your pharmacy quoted a price that made your stomach drop
• Your claim got rejected and you do not know why
• Your doctor said, "We need prior authorization," and you do not know what that means
• You have Select Health Medicare, Community Care, or FEHB and want a straight answer

This page is not for you if

• You are deciding whether Wegovy is medically right for you — that is a conversation with a licensed clinician
• You have SelectHealth from VNS Health in New York. That is a different plan from a different organization. Jump to the two-SelectHealth explanation.
• You are shopping for compounded semaglutide. This page is about FDA-approved Wegovy, and it does not treat compounded products as Wegovy.

The 30-second answer

Sources for every row appear in How we verified this. Commercial PDFs and plan documents were checked August 5, 2026.

Check Wegovy in your Select Health member account → (Official Select Health link. Not an affiliate link.)

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

What did we find inside Select Health's own drug lists?

Answer capsule: Select Health links to eight public commercial drug-list PDFs: six RxCore lists, one RxSelect list, and one RxBasic list for nonrenewable short-term plans. Wegovy has no text match in any of the eight. Each PDF has an anti-obesity category near the start, but no anti-obesity drug is listed before the next drug category begins.

We opened all eight PDFs and checked the anti-obesity section. We also searched the exact text "Wegovy" in every file.

Every list starts with a category called "ADHD / Anti-Narcolepsy / Anti-Obesity / Anorexiants." Open it and you will find ADHD medicines and wakefulness medicines.

You will not find Wegovy. You will not find Zepbound. You will not find Saxenda. You will not find an older anti-obesity drug under that category either.

The shelf is labeled. The shelf is empty.

That does not mean Select Health avoids all incretin-based drugs. In the Utah RxCore, Utah RxSelect, and Colorado RxCore lists we audited in full, Mounjaro and Trulicity appear in the diabetes section. Soliqua, an insulin/GLP-1 combination product, appears there too. Those entries do not establish coverage for Wegovy, and they do not make one drug an automatic substitute for another.

The RX Index eight-list audit

PA means prior authorization. QL means quantity limit. ST means step therapy.

The six RxCore PDFs and the RxBasic PDF were marked as published July 23, 2026. The RxSelect PDF was marked as published August 1, 2026. Select Health links to the current versions from its Pharmacy Coverage page.

What this proves, and what it does not

Here's the honest limit, and it matters.

Select Health says these PDFs are summaries of commonly prescribed covered drugs. It tells members to log in for the complete formulary and their exact benefit.

So a missing drug proves the public summary does not list it. It does not prove every specific commercial plan excludes it.

Some pages skip that sentence and declare universal noncoverage. That is not what the evidence supports, and we are not going to pretend otherwise.

What the audit does prove is useful anyway:

• You cannot pull a universal Select Health Wegovy tier or copay from these public PDFs. It is not there.
• A claimed public-PDF tier for Wegovy is not supported by the current eight documents.
• Wegovy is not shown as one of the commonly listed drugs in any of the eight current public commercial summaries we checked.
• A member still has to use the logged-in account or call the plan for the complete answer.

### What we actually verified On August 5, 2026, The RX Index reviewed Select Health's commercial pharmacy page, all eight public commercial drug-list PDFs, the anti-obesity section in every PDF, the full diabetes sections in three PDFs, a live RxSelect Wegovy PA form, the 2026 Medicare formulary change notice, a live Medicare Wegovy PA form, the Community Care provider bulletin, the 2026 FEHB formulary, Utah Medicaid's current PA directory, OPM's FEHB obesity-drug rules, current CMS Medicare GLP-1 Bridge rules, the FDA Wegovy label, Novo Nordisk's current price guide, Ro's coverage-checker page, and Sesame's Wegovy page. We could not see any individual member's logged-in commercial benefit. So we do not claim that every commercial plan covers Wegovy, that every plan excludes it, or that one tier, copay, or PA rule applies to everyone. Where the evidence stops, we say so.

Does SelectHealth cover Wegovy by plan type?

Answer capsule: Select Health does not use one Wegovy rule across every plan. Commercial coverage is plan-specific. Community Care excludes non-diabetic GLP-1 drugs used exclusively for weight loss. FEHB shows Zepbound rather than Wegovy. Standard Medicare removed Wegovy for 2026, while diagnosis-specific Part D review and the separate federal Bridge may still apply.

The RX Index Select Health Wegovy Coverage Matrix — version 1.0

The one sentence that matters most: the strongest true statement is not that Select Health covers or excludes Wegovy everywhere. It is that each coverage path produces a different answer — and a commercial member has to use the member's own benefit, not a public summary PDF.

How do I check whether my exact Select Health plan covers Wegovy?

Answer capsule: For a commercial Select Health member, the logged-in member account is the most accurate source. Select Health says the account shows whether a drug is covered and how the specific plan covers it. Search the exact Wegovy form and strength, save the result, and call Member and Pharmacy Services at 800-538-5038 if anything is unclear.

Five steps. About fifteen minutes. Do them in order.

Step 1 — Name your coverage path

Employer or individual? Short-term RxBasic? FEHB? Community Care? Medicare? Utah Medicaid fee-for-service?

If you do not know, look at your ID card and enrollment paperwork. Do not move forward with a generic, "I have SelectHealth." That is the mistake that costs people weeks.

Step 2 — Find your formulary name

A formulary is the plan's drug list.

Select Health uses two main commercial formularies:

• RxCore for individual, family, and employer plans; covered drugs can vary by state
• RxSelect, which Select Health describes as covering a wider range of medicines

There is also RxBasic for nonrenewable short-term plans.

Select Health says the formulary name appears in the member account and on the ID card. See Select Health's formulary instructions.

Step 3 — Search the exact product

Search the product your prescriber actually ordered:

• Wegovy injection — the weekly pen
• Wegovy tablet — the daily pill

Search the exact strength when the tool allows it. Plan tools can list separate forms and strengths as separate products.

Step 4 — Save what you see

Write down or screenshot:

• Covered, PA required, non-formulary, excluded, or another status
• Tier
• PA, QL, or ST flags
• Estimated price
• Product form and strength
• Date checked

Coverage documents change. Select Health's public lists have publication dates, and its Medicare page posts dated formulary changes. A dated screenshot gives you a clean record of what the plan displayed.

Step 5 — Call with a script, not a vague question

Read this word for word:

"I need to check Wegovy [injection or tablet, and the strength] under my pharmacy benefit, prescribed for [the true reason my clinician is treating]. Is it covered, prior authorization required, non-formulary, or an excluded benefit? If it needs authorization or an exception, what form, criteria, deadline, and estimated member cost apply?"

Then write down the name of the person you spoke with and the call reference number.

• Commercial Member and Pharmacy Services: 800-538-5038, option 2 for Pharmacy
• Community Care / Medicaid: 855-442-3234, option 2 for Pharmacy
• Select Health Medicare pharmacy questions: 855-442-9900, option 2 for Pharmacy
• Commercial PA-form questions for a prescriber's office: the live form lists 800-442-3129

Confirm current Select Health contact details.

SelectHealth Wegovy Coverage Path Checker

Five questions. No email. Nothing stored by default.

The checker asks:

1. What kind of Select Health coverage do you have?
2. Does your card say RxCore, RxSelect, Community Care, FEHB, Medicare, or something else?
3. Wegovy injection or tablet?
4. Why was it prescribed — weight management, cardiovascular risk reduction, MASH, or another reason?
5. What has happened so far — not checked, covered, PA, non-formulary, excluded, pharmacy rejection, or denial letter?

You get back: a plain-English explanation, the correct official phone number, a copy-and-paste call script, a prescriber document checklist, and the one next step that matches your status. It is printable.

Find my SelectHealth coverage path →

The tool tells you what to ask and where to ask it. It does not predict, guarantee, or grant coverage.

Does the reason Wegovy was prescribed change coverage?

Answer capsule: Yes. Wegovy has separate FDA-approved uses for chronic weight management and cardiovascular risk reduction. The injection also has an FDA-approved use for noncirrhotic MASH with moderate-to-advanced fibrosis. Plans can review those uses under different rules, so the product form and true prescribed reason must be part of every coverage question.

This is the single most overlooked lever on the whole page.

The same drug can be reviewed under different benefit rules because the prescribed use changes.

Weight management

This is the use most likely to hit an anti-obesity-drug exclusion. It is the use named in Community Care's exclusion. It is also the only use the Medicare GLP-1 Bridge is designed to cover.

Cardiovascular risk reduction

The FDA-approved Wegovy label includes reducing the risk of major cardiovascular events in certain adults with established cardiovascular disease and either obesity or overweight.

That matters for Medicare because a prescription for an FDA-approved cardiovascular use belongs under the Part D coverage and exception system, not the weight-management-only Bridge. Select Health's live Medicare Wegovy PA form has an established-cardiovascular-disease path.

A path is not a promise. But it is a real door, and most people do not know it is there.

MASH — a liver condition

MASH stands for metabolic dysfunction-associated steatohepatitis. It involves fat buildup, inflammation, and scarring in the liver.

The Wegovy injection has an FDA-approved use for adults with noncirrhotic MASH and moderate-to-advanced fibrosis, stages F2 to F3. The tablet does not carry the MASH use in the current FDA label.

Select Health's live Medicare form has a MASH path that asks about F2-F3 fibrosis, diagnostic confirmation, specialist involvement, and chart notes.

Make the paperwork name the truth

Ask your prescriber which FDA-approved use is being treated. Then ask the plan about that exact use and product form.

Make sure the request names the true medical reason your prescriber is treating — nothing else. Do not turn a weight-management request into another diagnosis just to chase coverage.

Read the current FDA Wegovy prescribing information.

Does SelectHealth require prior authorization for Wegovy?

Answer capsule: A live Select Health RxSelect commercial PA form includes Wegovy, so a review path exists for at least some commercial benefits. The form carries a 10/21 footer. It asks about age, BMI, listed weight-related conditions, reduced-calorie diet and activity, and response at renewal. It does not ask for documented past failed weight-loss programs.

Let's define the term first, because half the confusion comes from people using it wrong.

Prior authorization, often shortened to PA, means the plan wants the prescriber to submit medical information before the plan pays. It is a medical review. It is not the same thing as the drug being included in the benefit at all.

What the live commercial form actually asks

The live Select Health form includes:

• Wegovy and Zepbound among the requested medicines
• New request versus reauthorization
• Reduced-calorie diet and increased physical activity
• At least 5% weight loss from baseline for reauthorization
• Age
• Pediatric BMI percentile for Wegovy
• Adult BMI of at least 30, or at least 27 with listed weight-related conditions
• Additional comments and prescriber signature

The form also says missing, inaccurate, or incomplete information may delay or prevent authorization.

Open the live commercial Wegovy PA form.

Two things this form does not prove

One: it does not prove your plan includes the benefit. A form can exist for plans that use the criteria. Your member account and plan documents still control your coverage.

Two: the footer shows 10/21. That does not prove every question is the final 2026 rule for every plan. Ask for the version being used for your request today.

One thing we want to correct

Several pages state that Select Health requires documented past failed weight-loss attempts for Wegovy.

We looked. The live form does not ask that question. We also did not find a separate current Select Health commercial anti-obesity rule that supports the universal claim.

Do not let anyone tell you the request is doomed because you do not have years of program receipts. Ask the plan for the exact current criteria tied to your benefit.

Benefit inclusion comes before PA

This is the order:

1. Is Wegovy included, non-formulary, or excluded under your benefit?
2. If a review path exists, what PA or exception rule applies?
3. What did the prescriber's office submit?
4. What did the plan decide, and why?

More medical paperwork cannot fix the wrong problem. A PA can test medical criteria. It does not automatically add a benefit the plan design leaves out.

Getting the paperwork done

Send the current SelectHealth questions to your prescriber → — the checker builds a document list from your plan type, product form, prescribed use, and current status.

Now the honest part about outside help, because you are going to see it advertised everywhere.

Ro's free GLP-1 Insurance Coverage Checker does not check the Wegovy tablet. It checks the Wegovy pen. The free report also does not write a prescription or submit a treatment request or PA.

If you need tablet coverage, the Select Health account and plan phone number are the right first door.

But for the Wegovy pen, Ro says its insurance specialists will contact the insurer and send a free personalized coverage report. For someone staring at a plan result they do not understand, that phone-call friction is the bottleneck, solved.

Check your Wegovy pen coverage free with Ro → (Sponsored affiliate link)

Does that sound like your situation? Use the report to understand the plan result, then decide with your clinician what to do. The report is not an approval.

Provider-stated versus verified on August 5, 2026

Verification means we confirmed what each provider currently states on its own official page. The RX Index did not submit a test insurance request through either service for this article.

For the broader insurance process, see How to get insurance to cover a GLP-1.

What do "covered," "prior auth," "non-formulary," and "excluded" mean?

Answer capsule: These statuses require different responses. "Covered with PA" means the plan may pay after medical review. "Non-formulary" means the standard list does not include the drug, but an exception may exist. "Excluded" means the benefit or use is outside the plan design, so a standard PA alone usually will not solve it.

Getting this wrong is the most expensive mistake on this page. People can spend weeks appealing a decision that was never only a medical decision.

The one question that can save you weeks

Ask it exactly like this:

"Is Wegovy non-formulary under my plan, or is weight-management medication an excluded benefit?"

Non-formulary means an exception door may exist. Your prescriber may need to explain why the requested drug is medically necessary instead of a listed option.

Excluded means a standard PA alone usually will not add the missing benefit. Ask whether the plan offers any exception or appeal right, then confirm the plan design with the employer or other plan sponsor when one is involved.

Select Health says members, prescribers, or pharmacies may request case-by-case coverage of a drug that is not normally covered. That makes the exact word on the denial — non-formulary or excluded — worth getting in writing.

Read Select Health's pharmacy coverage FAQ.

What should I do if SelectHealth denies Wegovy?

Answer capsule: Start with the exact written denial reason, not a generic appeal template. Missing information, unmet medical criteria, non-formulary status, and a benefit exclusion are different problems with different responses. The deadline printed on your own denial letter is the deadline that controls.

If information was missing

Ask what exact item was missing. Have the prescriber's office correct or complete it and resubmit through the channel the plan gives you. Keep the submission reference number.

If the plan says medical criteria were not met

Ask for the exact criterion used. Compare it with the records that were submitted. Ask what review options the plan allows, such as more documentation or an appeal.

We are not going to tell you to hunt for magic words or reframe a diagnosis. Do not do that. Put the real records in front of the reviewer.

If the drug is non-formulary

Ask for the drug-exception process and the clinical information it requires. Ask which alternatives are on the formulary. Then have the prescriber explain why Wegovy is medically necessary when that is true.

If the benefit is excluded

Get the exclusion confirmed in writing. Then ask:

1. Is the whole anti-obesity-drug benefit excluded, or only this product or use?
2. Does the plan offer any exception or appeal path for the exclusion?
3. If this is an employer plan, did the employer choose the exclusion?
4. Is the true FDA-approved indication handled under a different benefit rule?

Do not keep sending the same PA after the plan has confirmed that PA is not the right process. Move to the exception, plan-sponsor, enrollment, or self-pay path that actually fits.

If the pharmacy rejected the claim

Ask the pharmacist:

• What rejection code came back?
• Does the plan require PA?
• Is the product form or strength wrong on the prescription?
• Is the pharmacy in network?
• Is the fill too early?
• Did the rejection come from the insurer, pharmacy system, or a manufacturer program?

A counter rejection is not always a final coverage decision. Get the code before assuming the worst.

About deadlines

Use the exact deadline printed on the denial letter. Commercial, FEHB, Medicaid, Medicare Part D, and the Medicare Bridge do not all use one appeal process.

One important difference: the Medicare GLP-1 Bridge has no formal appeal process. A prescriber can resubmit if information was wrong or new information is available. A regular Part D denial has its own exception and appeal rights.

Free download: SelectHealth Wegovy Denial Checklist

One page. No email required. Fill in:

• Exact denial language, word for word
• Date of denial
• Plan name and formulary
• Product form and strength
• True prescribed indication
• Claim or PA reference number
• Missing document or unmet rule
• Exception, appeal, correction, or plan-exclusion issue
• Deadline
• Name and reference number from every call

Download the SelectHealth Wegovy Denial Checklist →

For the broader insurance playbook, see How to get insurance to cover a GLP-1.

Does SelectHealth Medicare cover Wegovy in 2026?

Answer capsule: Wegovy appears on Select Health's 2026 Medicare deletion list and is not shown on the standard Essential Formulary, so routine formulary coverage is not the default answer. Select Health still has a Part D exception process and a live Wegovy PA form for cardiovascular disease and MASH. Weight-management-only requests may fit the separate $50 federal Bridge.

Three things are true at once here, and they do not contradict each other.

1. The standard list dropped Wegovy

Select Health's Q4 2025 P&T update lists Wegovy among the 2026 Medicare formulary deletions. Select Health says the 2026 Essential Formulary is used by every Select Health Medicare drug plan except the No Rx option.

The operational check is still the current Drug Lookup and member account. Select Health says the lookup is an estimate and the logged-in benefit is the better source for real cost.

• Select Health Medicare pharmacy benefits
• Select Health 2026 formulary change notice

2. Two diagnosis-specific Part D doors are visible

Select Health's live Medicare Wegovy PA form asks about:

• Established cardiovascular disease, including prior heart attack, prior stroke, or symptomatic peripheral artery disease, plus BMI of at least 27
• Noncirrhotic MASH with F2-F3 fibrosis, diagnostic confirmation, specialist involvement, and chart notes

Open the live Select Health Medicare Wegovy PA form.

This does not guarantee approval. It proves that the plan has a review form for those uses.

Select Health also allows a formulary exception request. Its Medicare page lists decision windows of 24 hours for an urgent request and 72 hours for a standard request.

• Medicare exception requests: 855-442-9988
• Medicare pharmacy questions: 855-442-9900, option 2 for Pharmacy

3. Weight management has a separate federal door

The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. Eligible members pay $50 for one monthly fill.

Read this next line twice, because it is where people get confused: the Bridge is not Select Health coverage. CMS runs it outside the normal Part D coverage and payment flow. A central processor handles the PA, claim, and pharmacy payment.

For this page, the key point is that the Bridge includes both Wegovy forms:

• Wegovy injection
• Wegovy tablets

Both forms are included when prescribed for the Bridge's weight-management use.

Basic Bridge eligibility

A person must be at least 18 and meet one of these starting-BMI paths:

• BMI of at least 35; or
• BMI of at least 30 with heart failure with preserved ejection fraction, specified uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher; or
• BMI of at least 27 with prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease

The prescriber must certify that the drug is being used with a diet-and-activity lifestyle program.

Who should stay in regular Part D instead

The Bridge is for weight management. It is not the route for a prescription being used for another Part D-coverable indication.

CMS says people with type 2 diabetes, moderate-to-severe sleep apnea, or MASH are not eligible for the Bridge based on those diagnoses; those requests belong with the Part D plan. A Wegovy prescription being used to reduce major cardiovascular events should also be routed to the Part D plan rather than the Bridge.

The $50 is separate from normal Part D math

CMS says:

• The Part D deductible does not apply
• The $50 does not count toward true out-of-pocket spending, or TrOOP
• The low-income subsidy does not reduce the $50
• Subsequent fills do not require a new PA unless the person switches to a different covered GLP-1 drug

There is no Bridge appeal

A prescriber can resubmit corrected or new information after a Bridge denial. CMS does not provide a formal Bridge appeal process. That is different from a normal Part D coverage denial, which keeps its regular exception and appeal rights.

Check whether you may qualify for the Medicare GLP-1 Bridge → (Official Medicare tool. Not an affiliate link.)

Read our full Medicare Wegovy coverage guide →

No provider recommendation belongs in this section. The official Part D and Bridge paths are the first moves.

Does SelectHealth Community Care cover Wegovy?

Answer capsule: Select Health Community Care excludes non-diabetic GLP-1 drugs used exclusively for weight loss. But that does not mean every Utah Medicaid path is closed. Utah fee-for-service is separate, and the current official PA directory still lists a GLP-1 form for weight-related comorbidities, updated June 19, 2026.

If a claim was rejected, the first question is not, "Did Utah Medicaid end coverage?" It is:

"Does Community Care or Utah fee-for-service process this pharmacy claim?"

Door one — Community Care ACO coverage

Select Health's February 2026 provider bulletin says weight-loss drugs remain excluded for ACOs and are only covered through fee-for-service. The same bulletin places non-diabetic GLP-1 drugs, including Wegovy and Zepbound, in the non-aligned category.

That is the clear answer for a Community Care member when Wegovy is used exclusively for weight loss: the ACO benefit excludes it.

Read the Select Health Community Care bulletin.

Door two — Utah Medicaid fee-for-service

This is where the easy answer breaks — and the difference matters.

An older Utah form warned that weight-management coverage was part of a legislative pilot and might not continue past June 30, 2026. That sentence did not prove the path ended.

On August 5, 2026, Utah Medicaid's current PA directory still listed "GLP-1 Medications for Weight-related Comorbidities" with a June 19, 2026 update date.

So the accurate answer is:

• Community Care's ACO door is closed for weight-loss-only coverage
• Utah fee-for-service remains a separate door with a current PA route listed
• A listed form does not guarantee approval
• The prescriber's office must use the current state criteria

Check Utah Medicaid's current prior-authorization directory.

Do not turn Wegovy into a diabetes drug

Wegovy is not FDA-approved to treat type 2 diabetes. Other GLP-1 brands may have diabetes indications and separate Medicaid rules, but that does not make Wegovy interchangeable with them.

Do not ask a prescriber to use a diagnosis that is not true. Ask which product and indication are actually being treated, then use the rule for that product and indication.

How to tell which Utah Medicaid path you have

Check:

• The plan name on the card
• The Utah Medicaid member portal
• The pharmacy-benefit information on the card
• The phone number on the card

Ask:

"Which entity processes my outpatient pharmacy claims — Select Health Community Care or Utah Medicaid fee-for-service?"

If it is Community Care, call 855-442-3234, option 2 for Pharmacy. If it is fee-for-service, have the prescriber's office use the current state PA directory.

One thing we will not do here: pitch a cash-pay program in the same breath as explaining Medicaid rules. Resolve the official coverage path first.

Does SelectHealth FEHB cover Wegovy?

Answer capsule: Wegovy is not shown on Select Health's published 2026 FEHB formulary. Zepbound appears at Tier 2 with prior authorization and a quantity limit. OPM requires FEHB carriers to cover at least one GLP-1 anti-obesity drug and at least two oral anti-obesity drugs, so the Select Health list appears to meet the GLP-1 floor with Zepbound rather than Wegovy.

This is one of the most useful comparisons on the page.

The federal floor almost nobody knows

The U.S. Office of Personnel Management runs the Federal Employees Health Benefits program.

OPM Carrier Letter 2023-01 says FEHB carriers:

• Cannot exclude anti-obesity medicines through a broad benefit exclusion or carveout
• Must make an exception process available
• Must cover at least one anti-obesity drug from the GLP-1 class for weight loss
• Must cover at least two additional oral anti-obesity options

Read OPM Carrier Letter 2023-01.

Now place that next to the commercial PDFs, where the public anti-obesity category is empty.

Same insurer. Different rulebook. An FEHB member has an OPM-set obesity-drug floor that may not exist in the same form under a commercial benefit.

The 2026 FEHB list shows Zepbound, not Wegovy

Select Health's published 2026 FEHB formulary shows:

• No Wegovy text match
• Zepbound at Tier 2 with PA and QL
• Oral anti-obesity drugs including phentermine, Qsymia, Contrave, orlistat, and Xenical

That combination appears to meet OPM's minimum formulary floor. It does not prove that a Wegovy exception will be approved.

Open the Select Health 2026 FEHB formulary.

What to say to the plan

"Wegovy is not shown on the published 2026 FEHB formulary. Is it non-formulary with an exception path, or is it handled another way under my benefit? What documentation would an exception require?"

Do not choose a medication from the formulary alone

A formulary tells you what the plan lists and prefers. It does not tell you which medicine is right for your body.

Zepbound and Wegovy are different FDA-approved medicines with different active ingredients, dosing, labels, and risks. Bring the formulary to the prescriber as information, not as the medical decision.

One more change coming in 2027

OPM released Carrier Letter 2026-07 on March 31, 2026 for plan year 2027.

For 2027, OPM says obesity coverage must include an intensive behavioral therapy program before and while an anti-obesity drug is covered. OPM says a simple member or provider statement about past attempts is not enough to bypass the structured program. Continued participation must be documented while the medicine is covered.

The required care path gets more structured in 2027. That is not a scare tactic. It is a calendar.

Read OPM's plan-year 2027 call letter.

Get the FEHB exception script → — the checker builds the wording from your current status.

What does Wegovy cost if SelectHealth will not pay?

Answer capsule: There is no single Select Health Wegovy price. A covered member's amount depends on the exact benefit, tier, deductible, and pharmacy. If the plan will not pay, Novo Nordisk's current self-pay prices range from $149 to $399 per month by form and strength. Eligible Medicare Bridge members pay $50 per monthly fill.

Let's deal with the number that scares people first.

Novo Nordisk currently lists Wegovy's list price as $1,349.02 per package for the pill, standard pen, and HD pen. That is the price before insurance or an eligible savings program. The manufacturer also offers lower self-pay prices and a commercial-insurance savings program.

If your plan covers Wegovy

Your real amount depends on:

• Tier
• Deductible
• Copay or coinsurance
• Pharmacy network
• Product form and strength
• Any manufacturer savings for which you qualify

The member account is the only place Select Health points to for the exact benefit. A universal Select Health Wegovy copay is not published in the public drug-list PDFs.

If your plan does not pay

Novo Nordisk's current price guide shows the following on August 5, 2026:

When you pay outside insurance, the amount does not count toward your plan deductible or out-of-pocket limit. Novo Nordisk can change or cancel the programs. Verify the price before filling.

• Wegovy cost and coverage page
• NovoCare Wegovy price guide

The honest order of operations

We would rather tell you the truth than route you somewhere profitable, so here is the right order:

1. Check the plan price first. It may be lower than self-pay, but do not assume it is.
2. If the plan will not pay, check NovoCare's current price for your exact form and strength. Do this before paying a separate service fee.
3. Pay for telehealth only when you need what it adds — a clinician, PA help, follow-up care, or another service you do not already have.

A telehealth fee pays for clinical or administrative service. It is not automatically a discount on the medicine.

If you need a clinician and want to compare visits before booking, Sesame lists clinicians who prescribe Wegovy when medically appropriate and says providers may assist with PA paperwork. (Sponsored affiliate link. Medication and approval are separate.)

Compare FDA-approved ways to get Wegovy without insurance →

Is "SelectHealth" the same company everywhere?

Answer capsule: No. Select Health is the Intermountain Health-related nonprofit plan serving more than one million members across the Mountain West. It added a space to its name in 2023. SelectHealth from VNS Health is a separate New York Medicaid HIV Special Needs Plan with its own service area, formulary, and phone number.

Quick, because you may be on the wrong page.

Select Health in Utah, Idaho, Nevada, and Colorado

This is the plan discussed throughout this article. Select Health announced its new branding in June 2023 and said the name change added a space between the words. It has offices in Utah, Idaho, Nevada, and Colorado and serves more than one million members across the Mountain West.

Read Select Health's rebrand announcement.

SelectHealth from VNS Health in New York

This is a separate specialized Medicaid plan for eligible people with HIV, transgender or gender-nonconforming people, people without stable housing, and dependent children.

Its service area includes the Bronx, Brooklyn, Manhattan, Queens, Nassau County, and Westchester County.

If this is your plan, the coverage rules above do not apply. Start at SelectHealthNY.org or call 1-866-469-7774.

What are Select Health members really trying to figure out?

Answer capsule: The search is rarely just, "Is Wegovy listed?" The real questions are why the pharmacy price is so high, what paperwork the plan wants, whether coverage changes from one employer or plan to another, and whether a denial means "try again" or "this benefit is not included."

These are the questions that keep showing up in public forums:

• Why did the pharmacy quote more than I can pay?
• What hoops does Select Health require?
• Can coverage change from one plan to another?
• Does prior authorization mean the drug is covered?
• Is my denial medical, formulary-based, or a benefit exclusion?
• Does Medicare's new $50 program apply to me?

Those questions show the friction. They are not coverage evidence. Your plan document and official program rules control.

"Can coverage vary by plan?" is the whole page in six words.

Yes. It can. That is exactly why the SelectHealth name on the card is not the full answer.

What is the fastest next step for my exact situation?

Answer capsule: The right next step depends on the status you already have. Someone who has not checked should start in the member account. Someone facing PA should involve the prescriber. Someone with a true benefit exclusion should stop repeating the same PA. A fee-for-service Medicaid member should use the state form, and an eligible Medicare member should use the correct Part D or Bridge path.

Find yourself. Do the one thing.

I have commercial Select Health and have not checked yet

Log in, find RxCore or RxSelect, search the exact Wegovy product and strength, and take a dated screenshot.

→ Check my member benefit

It says prior authorization required

Save the result. Send the current plan requirements and true prescribed use to the prescriber's office.

→ Build my prior-authorization checklist

→ Or, for the Wegovy pen, get Ro's free coverage report (sponsored affiliate link; report only, not a PA or prescription)

It says non-formulary

Ask for the exception process and the exact clinical information it requires. Do not assume a standard PA is the right form.

→ Get my exception questions

It says excluded

Confirm in writing whether the entire anti-obesity benefit is excluded or only this product or use. Ask whether any exception or appeal right exists before moving to cash pay.

→ Compare FDA-approved Wegovy access without insurance

I have Select Health Medicare

Ask whether the true prescribed use belongs under Part D review. If it is for weight management, check the federal Bridge separately.

→ Check Medicare GLP-1 Bridge eligibility

I have Community Care

Confirm that Community Care processes the drug claim. For weight-loss-only use, the ACO exclusion applies.

→ Call Community Care Pharmacy at 855-442-3234, option 2

I have Utah Medicaid fee-for-service

Have the prescriber's office open the current state PA directory and use the GLP-1 Medications for Weight-related Comorbidities form.

→ Check the current Utah Medicaid PA directory

I have FEHB

Ask whether Wegovy has a non-formulary exception path, and discuss Zepbound as a clinical choice — not as an automatic swap.

→ Get my FEHB exception script

I still do not know which treatment path fits

→ Get my personalized GLP-1 action plan

How did we verify this?

Answer capsule: The RX Index used Select Health's own documents for plan facts, Utah Medicaid for fee-for-service rules, CMS and Medicare for the federal Bridge, OPM for FEHB requirements, FDA labeling for approved uses, and Novo Nordisk for current Wegovy prices. We searched eight public commercial PDFs and separated what those files prove from what only a member account can show.

Who made this

This page was published by The RX Index. We are not affiliated with Select Health, Utah Medicaid, CMS, OPM, Novo Nordisk, Ro, or Sesame.

No clinician reviewed this page. We do not claim that one did.

How it was produced

On August 5, 2026, we opened and checked:

1. Select Health's commercial Pharmacy Coverage page
2. All eight public commercial drug-list PDFs linked from that page — six RxCore, one RxSelect, and one RxBasic
3. The anti-obesity section in all eight PDFs
4. The full diabetes section in the Utah RxCore, RxSelect, and Colorado RxCore PDFs
5. The live RxSelect commercial Wegovy PA form
6. Select Health's Q4 2025 P&T update showing 2026 Medicare deletions
7. The live Select Health Medicare Wegovy PA form
8. Select Health's Medicare Pharmacy Benefits page
9. Select Health's February 2026 Community Care provider bulletin
10. Utah Medicaid's current PA directory and current PDL page
11. Select Health's 2026 FEHB formulary
12. OPM Carrier Letter 2023-01
13. OPM Carrier Letter 2026-07 for plan year 2027
14. CMS and Medicare.gov Medicare GLP-1 Bridge pages
15. The current FDA Wegovy label
16. Novo Nordisk's current Wegovy cost page and one-page price guide
17. Ro's current GLP-1 Insurance Coverage Checker page
18. Sesame's current Wegovy page
19. Select Health's 2023 rebrand announcement
20. VNS Health SelectHealth's official New York site

What we could not verify

• No member's logged-in commercial benefit. We cannot see your plan.
• No universal commercial Wegovy tier or copay. The public PDFs do not publish one.
• No reliable Select Health approval-rate data. We found no primary source for precise approval percentages published elsewhere.
• No universal 2026 commercial PA criteria. The live commercial form has a 10/21 footer.
• No guarantee from the Utah fee-for-service form. A current listing proves a route exists, not that a request will be approved.
• No independent test of Ro or Sesame for this article. We verified what their current official pages state.

Why this page exists

Because the insurer name alone does not answer the question, and the real answer is scattered across commercial formularies, a dated PA form, Medicare documents, a federal Bridge, Community Care rules, Utah fee-for-service rules, and FEHB requirements.

Some pages treat missing data as permission to guess.

We would rather show you where the answer lives than pretend we already have it.

Source hierarchy

When sources could conflict, we used this order:

1. The member's own plan result or formal coverage notice
2. Current government or regulator materials
3. Current Select Health plan documents
4. Current manufacturer materials for prices and product-program terms
5. Provider pages for what that provider currently states
6. Editorial guidance based on the verified facts above

Version log

We update the visible verification date only after rechecking the source set. Fixing a typo does not move the date.

Frequently asked questions

Is Wegovy on the SelectHealth commercial formulary?

Wegovy has no text match in any of the eight public 2026 commercial drug-list PDFs we checked. But Select Health calls those PDFs summaries and directs members to the logged-in account for the complete plan result. Check the account before deciding that your specific plan covers or excludes it.

Does SelectHealth cover Wegovy for weight loss?

It depends on the coverage path. Community Care excludes non-diabetic GLP-1 drugs used exclusively for weight loss. Utah fee-for-service has a separate current PA route listed. Standard Select Health Medicare removed Wegovy for 2026, while eligible Part D members may use the federal Bridge for weight management. Commercial members must check the exact benefit.

Does my employer decide whether Wegovy is covered?

For an employer plan, the employer's selected benefit design can affect whether anti-obesity drugs are included. Ask Select Health and the employer benefits team whether Wegovy is covered with PA, non-formulary, or part of an excluded benefit. Those answers lead to different next steps.

What is the difference between RxCore and RxSelect?

They are Select Health commercial formularies. RxCore is used for individual, family, and employer plans and can vary by state. Select Health describes RxSelect as covering a wider range of medicines. RxBasic is separate and applies to nonrenewable short-term plans. The formulary name appears in the member account and on the ID card.

Does SelectHealth require prior authorization for Wegovy?

A live RxSelect Wegovy PA form exists, so a review path is available for at least some commercial benefits. The form has a 10/21 footer. Verify that your plan includes or will consider the drug, then ask which current form and rule apply.

Does SelectHealth require proof that I tried to lose weight before?

Do not assume so. The live commercial form asks about BMI, age, reduced-calorie diet, physical activity, listed conditions, and response at renewal. It does not ask for documented past failed weight-loss programs. A different plan-specific rule could exist, so ask for the exact current criterion.

Can prior authorization override a benefit exclusion?

A standard PA usually cannot add a benefit the plan design excludes. First ask whether Wegovy is non-formulary or whether anti-obesity-drug coverage is excluded. Then ask whether an exception or appeal right exists.

Does SelectHealth cover Wegovy for cardiovascular disease?

The FDA label includes a cardiovascular-risk-reduction use for certain adults with established cardiovascular disease and obesity or overweight. Select Health's live Medicare Wegovy PA form has an established-cardiovascular-disease path. That is a review path, not an approval promise, and commercial coverage must be checked separately.

Does SelectHealth cover Wegovy for MASH?

The Wegovy injection has an FDA-approved use for adults with noncirrhotic MASH and F2-F3 fibrosis. Select Health's live Medicare form contains a MASH review path. The tablet does not have the MASH use in the current FDA label, and a Medicare form does not establish commercial coverage.

Does SelectHealth cover the Wegovy tablet?

Search the tablet separately from the injection in the member account. The public commercial summaries do not establish universal coverage for either form. The Medicare GLP-1 Bridge includes Wegovy tablets and injection for eligible weight-management requests.

Can Select Health Medicare members use the $50 Bridge?

Eligible members with a qualifying Medicare Part D plan may use the federal Bridge for a covered weight-management prescription. CMS runs it outside the normal Part D payment flow. It runs through December 31, 2027 and uses a $50 monthly copay.

Can I appeal a Medicare GLP-1 Bridge denial?

The Bridge has no formal appeal process. A prescriber may resubmit corrected or new information. A denial from the regular Part D plan is different and keeps the plan's normal exception and appeal rights.

Does SelectHealth Community Care cover Wegovy?

For use exclusively for weight loss, Community Care's ACO benefit excludes non-diabetic GLP-1 drugs such as Wegovy and Zepbound. Utah fee-for-service is separate and still has a current GLP-1 weight-related-comorbidities PA form listed.

Did Utah Medicaid's Wegovy path end June 30, 2026?

The current official evidence does not support saying the whole fee-for-service path ended. An older form said the pilot might not continue past June 30. The current Utah Medicaid PA directory still listed the GLP-1 weight-related-comorbidities form on August 5, with a June 19, 2026 update date.

Does SelectHealth FEHB cover Wegovy?

Wegovy is not shown on the published 2026 FEHB formulary. Zepbound is shown at Tier 2 with PA and QL. OPM requires a GLP-1 anti-obesity option and an exception process, so ask whether Wegovy may be requested as a non-formulary exception.

Does SelectHealth cover Zepbound or Ozempic?

Zepbound appears on the Select Health FEHB list at Tier 2 with PA and QL. The public commercial anti-obesity sections we checked do not list Zepbound. Ozempic is a separate FDA-approved diabetes brand and should be checked under the exact plan; it is not Wegovy and is not an automatic weight-management substitute.

Is Wegovy a diabetes medicine?

No. Wegovy is not FDA-approved to treat type 2 diabetes. Semaglutide is used in other FDA-approved products with different names and labels, but coverage for one brand does not establish coverage for another.

Will SelectHealth cover compounded semaglutide?

Compounded semaglutide is not Wegovy. Compounded drugs are not FDA-approved, and this page does not treat a compounded product as interchangeable with FDA-approved Wegovy. Ask the plan about the exact product, but do not use a compounded-product answer as evidence of Wegovy coverage.

How much will Wegovy cost with SelectHealth?

If the plan covers it, the amount depends on the exact benefit, tier, deductible, pharmacy, and savings eligibility. The public PDFs do not publish one universal copay. Novo Nordisk's current self-pay prices range from $149 to $399 per month by form and strength, while eligible Medicare Bridge members pay $50 per monthly fill.

What should I do after a denial?

Get the written reason first. Missing information, unmet medical criteria, non-formulary status, a benefit exclusion, and a Bridge denial require different responses. Use the deadline and process stated in the official notice.

Does Select Health coverage differ in Utah, Idaho, Nevada, and Colorado?

RxCore coverage can vary by state, and employer plan design can add another layer. Select Health tells commercial members to use the state tied to where they live or where the employer is based, then check the logged-in account for the exact benefit.

Three steps, and you are done

1. Name your coverage path. Commercial, FEHB, Community Care, Utah fee-for-service, Select Health Medicare, or the federal Bridge.
2. Check the exact product and true prescribed use. Injection or tablet. Weight management, cardiovascular risk reduction, MASH, or another reason. Save the result.
3. Follow the matching path. PA, formulary exception, plan-design question, Utah FFS form, Medicare Part D review, the Medicare Bridge, or self-pay.

That's it. That's the whole thing. Most people who get stuck on this get stuck because they skipped step one.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

Sources

Select Health

• Commercial Pharmacy Coverage and public drug-list links
• Select Health contact numbers
• Commercial RxSelect Wegovy PA form
• Select Health Medicare Pharmacy Benefits
• Q4 2025 P&T update with 2026 Medicare formulary changes
• Select Health Medicare Wegovy PA form
• February 2026 Community Care provider bulletin
• Select Health 2026 FEHB formulary
• Select Health 2023 rebrand announcement

Utah Medicaid

• Current Utah Medicaid prior-authorization directory
• Current Utah Medicaid Preferred Drug List page

Federal sources

• OPM Carrier Letter 2023-01 — Prevention and Treatment of Obesity
• OPM Carrier Letter 2026-07 — plan-year 2027 call letter
• CMS Medicare GLP-1 Bridge
• CMS Bridge information for providers
• Medicare.gov weight-loss-drug and Bridge eligibility page
• FDA Wegovy prescribing information
• FDA compounding questions and answers

Pricing and provider-stated service details

• Wegovy cost and coverage page
• NovoCare Wegovy page
• NovoCare Wegovy one-page price guide
• Ro GLP-1 Insurance Coverage Checker
• Sesame Wegovy page

Name disambiguation

• VNS Health SelectHealth in New York

This page gives general information about insurance coverage, not medical advice. Wegovy is a prescription medicine with risks and side effects, including a boxed warning about thyroid C-cell tumors. Only a licensed clinician can decide whether it is appropriate for you. Coverage and prices can change, so confirm with the plan or program before acting. Compounded semaglutide is not FDA-approved Wegovy and is not treated as equivalent on this page.